LGBTQ-Inclusive Care Training for Alzheimer's Disease

(MILLS Trial)

SR
Overseen BySimon Rosser, PhD,MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Minnesota
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to enhance care for LGBTQ+ individuals with Alzheimer's and related dementias by training long-term care providers in culturally responsive practices. It compares the effectiveness of in-person versus online training programs, specifically the eTTS online training and the Training to Serve (TTS) in-person training. The trial seeks nursing or housing service providers in Minnesota willing to participate in policy reviews and who have a team of at least five managers and five staff. Participants must be able to speak and read English. As an unphased trial, this study offers a unique opportunity to contribute to improving care practices for LGBTQ+ individuals.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this training is safe for improving SGM culturally responsive care?

Research has shown that the "Training to Serve" programs, available both online (eTTS) and in person, are safe and easy to handle. More than 12,000 workers in long-term care services across 12 states have completed the training, finding it practical and well-received.

No reports of negative effects have emerged from these training programs, which aim to improve care for sexual and gender minority individuals with Alzheimer's Disease and related dementias. The training has increased caregivers' knowledge and confidence, proving it helpful without causing harm.

Overall, these findings confirm the safety of both the online and in-person training methods. Participants can feel assured about the safety of taking part in this training.12345

Why are researchers excited about this trial?

Researchers are excited about these training programs because they aim to enhance LGBTQ-inclusive care in Alzheimer's treatment settings, an area often lacking in existing protocols. Unlike traditional Alzheimer's care, which may not specifically address the unique needs of LGBTQ individuals, these trainings focus on increasing healthcare providers' awareness and competence in serving sexual and gender minority clients. The online versions (eTTS) offer flexibility for participants to complete the modules at their own pace, making it accessible for busy healthcare professionals, while the in-person TTS provides an interactive, immersive learning experience. This dual approach could significantly improve providers' comfort and effectiveness in delivering inclusive care, which is crucial for a more equitable healthcare system.

What evidence suggests that this trial's training programs could be effective for improving SGM culturally responsive care in Alzheimer's Disease?

Research has shown that the "Training to Serve" program, available both online (eTTS) and in person (TTS), has successfully trained over 12,000 long-term care workers in 12 states. This trial will evaluate the effectiveness of both training methods in improving care for sexual and gender minority (SGM) individuals with Alzheimer's Disease and similar conditions. Past applications have found the training well-received and practical. Early results suggest that this approach can enhance the quality of care for SGM older adults, making it a promising tool for improving their care experience. Both training methods focus on increasing caregivers' understanding and sensitivity, which is essential for effective dementia care.678910

Who Is on the Research Team?

SR

Simon Rosser, PhD,MPH

Principal Investigator

University of Minnesota

TS

Tetyanna Shippee, PhD

Principal Investigator

University of Minnesota

Are You a Good Fit for This Trial?

This trial is for licensed Minnesota nursing or housing services staff who manage or supervise at least 5 people. They must be willing to review policies and environment now and in 6 months, and speak/read English. It's not for those unable to communicate in English.

Inclusion Criteria

I am willing to review policies and environment now and in 6 months.
Having at least 5 managers/supervisors and 5 staff
Licensure in Minnesota to provide nursing and/or as a housing with services establishment

Exclusion Criteria

Participants who cannot speak and read English

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Training

Participants undergo either in-person or online training to improve SGM culturally responsive care

1 day for in-person, 1-2 hours for online
1 visit (in-person) or online access

Post-Intervention Assessment

Participants complete post-intervention surveys to assess knowledge, attitudes, and skills

Immediately post-intervention

Follow-up

Participants are monitored for changes in organizational factors and staff competencies

6 months
Follow-up survey

What Are the Treatments Tested in This Trial?

Interventions

  • eTTS online training
  • Training to Serve online training (eTTS)
  • Training to Serve (TTS) in person training
  • TTS in person training
Trial Overview The study compares two training programs aimed at improving care for LGBTQ seniors with Alzheimer's or related dementia: an in-person program (TTS) versus an online version (eTTS), against a waitlist control group, to see which is more effective.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Training to Serve online training (eTTS)Experimental Treatment1 Intervention
Group II: Training to Serve (TTS) in person trainingExperimental Treatment1 Intervention
Group III: Waitlist controlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Published Research Related to This Trial

The Innovations in Dementia Empowerment and Action (IDEA) trial is the first randomized controlled trial designed specifically for sexual and gender minority (SGM) older adults with dementia, aiming to address their unique needs through a culturally responsive intervention.
IDEA enhances the existing Reducing Disability in Alzheimer's Disease (RDAD) program by incorporating empowerment practices that focus on SGM-specific issues like discrimination and stigma, with expected outcomes including improved physical activity, reduced stress, and increased social support.
Design and development of the first randomized controlled trial of an intervention (IDEA) for sexual and gender minority older adults living with dementia and care partners.Fredriksen-Goldsen, K., Teri, L., Kim, HJ., et al.[2023]
An online training module for long-term care staff significantly increased their knowledge about the unique needs of LGBT Veterans, highlighting the importance of cultural competence in healthcare settings.
While the training improved knowledge, it did not significantly change staff skills or attitudes, suggesting that further training may be needed to translate knowledge into practice for better care of LGBT residents.
Serving All Who Served: Piloting an Online Tool to Support Cultural Competency with LGBT U.S. Military Veterans in Long-Term Care.Donaldson, W., Smith, HM., Parrish, BP.[2020]
The Alzheimer's Society of Lower Saxony developed a comprehensive training program for hospital staff to improve care for patients with cognitive impairment or dementia, which included a 14-hour training for staff and a 160-hour qualification for trainers.
The initiative was recognized with prestigious awards in 2012, highlighting its effectiveness and impact on enhancing the treatment and care of dementia patients in general hospitals.
Caring for people with dementia in general hospitals: an education curriculum from the Alzheimer's Society of Lower Saxony, Germany.Gurlit, S., Thiesemann, R., Wolff, B., et al.[2021]

Citations

RePORT RePORTER - National Institutes of Health (NIH) |The randomized controlled trial will rigorously test the effects of an in- person versus an online training program on improving SGM culturally responsive care.
RePORT RePORTER - National Institutes of Health (NIH) |This application is focused on the Training to Serve curriculum, which has trained over 12,000 LTSS workers in 12 states. This acceptable, feasible, and ...
New study designed to improve the care of sexual and gender ...The study will involve the first evidence-based training for the care of SGM older adults with AD/ADRD, and the first randomized control study on this ...
Review Article Dementia training for healthcare professionalsWe aimed to explore how dementia training is best delivered to healthcare workers to improve dementia care and worker wellbeing.
Project DetailsThis application is focused on the Training to Serve curriculum, which has trained over 12,000 LTSS workers in 12 states. This acceptable, feasible, and ...
Project DetailsThe randomized controlled trial will rigorously test the effects of an in- person versus an online training program on improving SGM culturally responsive care.
Alzheimer's Disease Programs Initiative (ADPI)• Health promoter: Deliver person-centered, relevant dementia education to people living with dementia and/or caregivers; Train individuals ...
Award Information | HHS TAGGSLeadership Training in Real-World Data Analytics: Sleep and Alzheimer's Disease. Award Number: K02AG095384. ORGANIZATION: NATIONAL INSTITUTE ...
Dementia Models of Care GranteesTraining caregivers with culturally responsive resources. Developing culturally tailored care plans. Launching a Caregiver Champion mentorship network ...
Competency‐based training boosts dementia knowledge ...The training significantly improved caregivers' dementia knowledge and self‐efficacy but did not reduce caregivers' distress and depression, nor ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security